187 related articles for article (PubMed ID: 33070077)
1. Management of chemotherapy-induced alopecia (CIA): A comprehensive review and future directions.
Haque E; Alabdaljabar MS; Ruddy KJ; Haddad TC; Thompson CA; Lehman JS; Hashmi SK
Crit Rev Oncol Hematol; 2020 Dec; 156():103093. PubMed ID: 33070077
[TBL] [Abstract][Full Text] [Related]
2. A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.
Dunnill CJ; Al-Tameemi W; Collett A; Haslam IS; Georgopoulos NT
Oncologist; 2018 Jan; 23(1):84-96. PubMed ID: 28951499
[TBL] [Abstract][Full Text] [Related]
3. The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review.
Marks DH; Okhovat JP; Hagigeorges D; Manatis-Lornell AJ; Isakoff SJ; Lacouture ME; Senna MM
Breast Cancer Res Treat; 2019 Jun; 175(2):267-276. PubMed ID: 30806923
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis.
Shin H; Jo SJ; Kim DH; Kwon O; Myung SK
Int J Cancer; 2015 Mar; 136(5):E442-54. PubMed ID: 25081068
[TBL] [Abstract][Full Text] [Related]
5. Scalp hypothermia as a preventative measure for chemotherapy-induced alopecia: a review of controlled clinical trials.
Shah VV; Wikramanayake TC; DelCanto GM; van den Hurk C; Wu S; Lacouture ME; Jimenez JJ
J Eur Acad Dermatol Venereol; 2018 May; 32(5):720-734. PubMed ID: 28976026
[TBL] [Abstract][Full Text] [Related]
6. Scalp cooling: management option for chemotherapy-induced alopecia.
Roe H
Br J Nurs; 2014 Sep 11-24; 23(16):S4, S6, S8 passim. PubMed ID: 25203854
[TBL] [Abstract][Full Text] [Related]
7. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
Smetanay K; Junio P; Feißt M; Seitz J; Hassel JC; Mayer L; Matthies LM; Schumann A; Hennigs A; Heil J; Sohn C; Jaeger D; Schneeweiss A; Marmé F
Breast Cancer Res Treat; 2019 Jan; 173(1):135-143. PubMed ID: 30255454
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis and treatment options for chemotherapy-induced alopecia: a systematic review.
Rubio-Gonzalez B; Juhász M; Fortman J; Mesinkovska NA
Int J Dermatol; 2018 Dec; 57(12):1417-1424. PubMed ID: 29377091
[TBL] [Abstract][Full Text] [Related]
10. Scalp Cooling: A Literature Review of Efficacy, Safety, and Tolerability for Chemotherapy-Induced Alopecia
.
Ross M; Fischer-Cartlidge E
Clin J Oncol Nurs; 2017 Apr; 21(2):226-233. PubMed ID: 28315539
[TBL] [Abstract][Full Text] [Related]
11. Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
Wikramanayake TC; Haberland NI; Akhundlu A; Laboy Nieves A; Miteva M
Curr Oncol; 2023 Mar; 30(4):3609-3626. PubMed ID: 37185388
[TBL] [Abstract][Full Text] [Related]
12. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M
JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254
[TBL] [Abstract][Full Text] [Related]
13. Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.
van den Hurk CJ; van den Akker-van Marle ME; Breed WP; van de Poll-Franse LV; Nortier JW; Coebergh JW
Eur J Oncol Nurs; 2013 Oct; 17(5):536-40. PubMed ID: 23571182
[TBL] [Abstract][Full Text] [Related]
14. The DigniCap Scalp Cooling System and its use in the treatment of chemotherapy-induced alopecia.
Mustoe MM; Lee CM; Melisko ME; Esserman LJ; Rugo HS
Future Oncol; 2018 Oct; 14(24):2461-2469. PubMed ID: 30001151
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced alopecia.
Trüeb RM
Semin Cutan Med Surg; 2009 Mar; 28(1):11-4. PubMed ID: 19341937
[TBL] [Abstract][Full Text] [Related]
16. Patient-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia.
Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Smorenburg CH; van der Hoeven JJM
Eur J Oncol Nurs; 2018 Apr; 33():49-55. PubMed ID: 29551177
[TBL] [Abstract][Full Text] [Related]
17. The Influence of Various Parameters on the Success of Sensor-Controlled Scalp Cooling in Preventing Chemotherapy-Induced Alopecia.
Schaffrin-Nabe D; Schmitz I; Josten-Nabe A; von Hehn U; Voigtmann R
Oncol Res Treat; 2015; 38(10):489-95. PubMed ID: 26451590
[TBL] [Abstract][Full Text] [Related]
18. Results of 20- versus 45-min post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia.
Komen MM; Breed WP; Smorenburg CH; van der Ploeg T; Goey SH; van der Hoeven JJ; Nortier JW; van den Hurk CJ
Support Care Cancer; 2016 Jun; 24(6):2735-41. PubMed ID: 26805558
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia.
Komen MM; Smorenburg CH; van den Hurk CJ; Nortier JW
Oncologist; 2013; 18(7):885-91. PubMed ID: 23650021
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness, Safety, and Tolerance of Scalp Cooling for Chemotherapy-Induced Alopecia.
Zhang XY; Yang KL; Liu WQ; Huang J; Ning N
Oncol Nurs Forum; 2022 Jun; 49(4):369-384. PubMed ID: 35788740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
